MarketInOut Stock Screener Log In | Sign Up

Shandong Boan Biotechnology Co Ltd

HKSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Shandong Boan Biotechnology Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization1,963.63 mln
Float118 mln
Earnings Date03/29/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.16
Caution advised

Relative Strength

88 / 100
Strongly outperforming

Debt / Equity

0.33
Low leverage

Pre-Tax Margin

-16%
Loss-making

ROE

-3.92
Negative

Business Description

Shandong Boan Biotechnology is a Chinese biopharmaceutical company that develops and sells biological medicines targeting cancer, bone disease, diabetes, and other serious conditions. Its approved products include treatments for multiple cancer types, osteoporosis, and bone tumors, while its pipeline spans a range of therapies in various stages of clinical testing. Founded in 2013 and based in Yantai, China, the company operates as part of the larger Shandong Luye Pharmaceutical group.

Key Fundamentals

EPS-0.18
ROE-3.92
ROIC-2.81
ROA-2.51
EBITDA, mln45.96
EV / EBITDA33.27
EV / EBIT-24.04
Revenue, mln694
EV / Revenue2.20

Quote Details

Last 3.15
Change -0.01 (-0.32%)
Open 3.19
Volume 182,200
Turnover 573,930
Average Volume 568,704

Financial Ratios

Pre-Tax Profit Margin-16
Current Ratio1.74
Price / Book0.59
Price / Tangible Book1.31
Debt / Equity0.33
Price / Sales2.59

Financial Strength

Altman Z-Score1.07
Piotroski F-Score 5 / 9
Beneish M-Score-2.16

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.56% 48 / 100   
1 Month 6.78% 88 / 100   
2 Months -36.11% 11 / 100   
6 Months -53.74% 10 / 100   
1 Year -72.32% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog